BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17045584)

  • 1. Human cyclooxygenase-1b is not the elusive target of acetaminophen.
    Censarek P; Freidel K; Hohlfeld T; Schrör K; Weber AA
    Eur J Pharmacol; 2006 Dec; 551(1-3):50-3. PubMed ID: 17045584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain research. Enzyme might relieve research headache.
    Wickelgren I
    Science; 2002 Sep; 297(5589):1976. PubMed ID: 12242413
    [No Abstract]   [Full Text] [Related]  

  • 3. Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat.
    Snipes JA; Kis B; Shelness GS; Hewett JA; Busija DW
    J Pharmacol Exp Ther; 2005 May; 313(2):668-76. PubMed ID: 15650114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases.
    Aronoff DM; Oates JA; Boutaud O
    Clin Pharmacol Ther; 2006 Jan; 79(1):9-19. PubMed ID: 16413237
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
    Botting RM
    Clin Infect Dis; 2000 Oct; 31 Suppl 5():S202-10. PubMed ID: 11113024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.
    Chandrasekharan NV; Dai H; Roos KL; Evanson NK; Tomsik J; Elton TS; Simmons DL
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13926-31. PubMed ID: 12242329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
    Hersh EV; Lally ET; Moore PA
    Curr Med Res Opin; 2005 Aug; 21(8):1217-26. PubMed ID: 16083531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues.
    Warner TD; Vojnovic I; Giuliano F; Jiménez R; Bishop-Bailey D; Mitchell JA
    J Pharmacol Exp Ther; 2004 Aug; 310(2):642-7. PubMed ID: 15148345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.
    Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM
    Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicine: lipid signals in pain control.
    Bazan NG; Flower RJ
    Nature; 2002 Nov; 420(6912):135-8. PubMed ID: 12432374
    [No Abstract]   [Full Text] [Related]  

  • 11. Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
    Qin N; Zhang SP; Reitz TL; Mei JM; Flores CM
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1298-305. PubMed ID: 16141368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracetamol-inhibitable COX-2.
    Botting R
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):609-18. PubMed ID: 11192935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on "acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties".
    Simmons DL; Chandrasekharan NV; Hu D; Roos KL; Tomsik J
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1412-4; author reply 1415-6. PubMed ID: 16291877
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3.
    Davies NM; Good RL; Roupe KA; Yáñez JA
    J Pharm Pharm Sci; 2004 Jul; 7(2):217-26. PubMed ID: 15367379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting.
    Censarek P; Steger G; Paolini C; Hohlfeld T; Grosser T; Zimmermann N; Fleckenstein D; Schrör K; Weber AA
    Thromb Haemost; 2007 Dec; 98(6):1309-15. PubMed ID: 18064329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracetamol (Acetaminophen): mechanisms of action.
    Anderson BJ
    Paediatr Anaesth; 2008 Oct; 18(10):915-21. PubMed ID: 18811827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.
    Boutaud O; Aronoff DM; Richardson JH; Marnett LJ; Oates JA
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7130-5. PubMed ID: 12011469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinociceptive mechanism of action of paracetamol].
    Bonnefont J; Courade JP; Alloui A; Eschalier A
    Drugs; 2003; 63 Spec No 2():1-4. PubMed ID: 14758785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties.
    Kis B; Snipes JA; Busija DW
    J Pharmacol Exp Ther; 2005 Oct; 315(1):1-7. PubMed ID: 15879007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COX-3: is it the target of acetaminophen?].
    Wu MJ; Wan JY
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):40-2. PubMed ID: 21417014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.